Thus, we observed increased percentages of plasmablasts, DC-SIGN+B-cells and CD83+B-cells in blood from SPMS, and DC-SIGN+B-cells and disease progression correlated in SPMS. Here, CD209 is linked to secondary progressive multiple sclerosis.